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Abstract A tyrosine-phosphorylated protein with a molecular 
mass of 115 kDa was reported to be tightly associated with the 
!~ regulatory subunit of phosphatidylinositol (Pl) 3-kinase, 
when the enzyme was essentially activated upon Hgand engage- 
ment of Fey receptors (FeTR) leading to engulfment of IgG- 
coated erythroeytes by phagocytes [Ninomlya et al. (1994) J. 
Biol. Chem. 269, 22732-22737]. Here, the 115.kDa protein is 
identified as the product of human c.eM protooneogene. Cross- 
linking of FcTRII on the surface of THP-I cells triggered (a) 
prominent tyrosine phosphorylation of Cbl, (b) activation of Pl 
3-kluase that was immunopreeipitated wltil the antI-Cbl or the 
anti-phosphotyroslne antibody, and (c) specific association of Cbl 
with !~.  Thus, Cbl functions in phagocytes as a result of its 
association with Pl 3-kinase in response to Fc'yR ligation. 
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1. Introduction 
Immune complex- or opsonized antigen-mediated cross- 
linking of Fc receptors for lgG (Fq, R) on the surface of 
phagocyte activates their various biological functions such 
as phagocytosis, exocytosis, and superoxide anion production. 
Although much is known about the gene and protein struc- 
ture of Fq, R [1-3], the intracellular signal transduction system 
arising from the receptor stimulation has not been well estab- 
lished. Numerous tudies have suggested that the system in- 
volves activation of intracellular protein tyrosine kinases uch 
as Lyn, Fyn, Fgr, Hck, Yes and ~yk, as a result of cross- 
linking of Fc~R [4-10]. Although relatively few tyrosine phos- 
phorylated peptides have as yet been identified, a protoonco- 
gene product, Cbl, has recently attracted attention among 
them [5]. Cbl is tyrosine phosphorylated upon stimulation of 
T-cell receptor, B-cell receptor and some cytokine receptors a
well [11-17]. Some Src family tyrosine kinases are reported to 
be associated with Cbl in hematopoietic cells [5,12,15]. Thus, 
Cbl emerges as a potential player in immune recognition re- 
ceptor signaling. 
Pl 3-kinase is a lipid kinase which catalyzes phosphoryla- 
tion at the D-3 position of the inositol ring of PI, PI 4-phos- 
phate, and PI 4,5-bisphosphate (for review, see refs. [18-20]). 
The activity of this enzyme in cells increases upon stimulation 
of a number of growth factor receptors having intrinsic tyr- 
osine kinase activities, s, ::: as those for platelet-derived 
growth factor, epidermal growth factor, insulin, and colony 
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Abbreviations: FcyR, Fc receptor for IgG; Pl, phosphatidylinositol; 
p85, 85-kDa subunit of Pl 3-kinase; PI-3P, PI 3.phosphate 
stimulating factor-I [21-26]. PI 3-kinase has also been acti- 
vated after stimulation of a variety of the receptors lacking 
tyrosine kinase domains. These tyrosine kinase-lacking recep- 
tors include cytokine receptors, T-cell and B-cell antigen re- 
ceptors [2%33]. Most of the latter eceptors, when stimulated, 
are physically associated with and activate Src-type tyrosine 
kinases. The latest paper has reported that Pl 3-kinase associ- 
ates with Cbl upon activation through TCR/CD3 or immu- 
noglobulin complex in jurkat T cells [12,13,15]. 
Previously, we have reported that stimulation of Fc~/R by 
the antibody cross-linking ives rise to increased Pl 3-kinase 
activity in the anti-phosphotyrosine-precipitable fr ction pre- 
pared from whole cell lysate in the mono ytic U937 cell line 
[34]. A specific inhibitor of Pl 3-kina,:~, wortmannin [35], 
completely inhibits endocytosis of IgOr.coated sheep erythro- 
cytes that has been bound to Fc~P, affording evidence for an 
indispensable role of PI 3-kinase activation in signaling cas- 
cades arising from the receptor stimulation and leading to this 
eventual cellular esponse [34]. We have also indicated that a 
tyrosine-phosphorylated 115-kDa protein may communicate 
between FcyR-coupled Src-type tyrosine kinase and Pl 3-ki- 
nase by binding to the SH2 domain of the p85 regulatory 
subunit of the enzyme [34]. Her¢, we report on identification 
of the l l5-kDa protein as Cbl. 
2. Materials and methods 
2.1. Materials 
Mouse monoclonal ntibody IV.3 (anti-FcyRll) was from Medarex 
(East Annandale, NJ); F(ab'h fragment of goat anti-mouse IgG 
(H+L) from Jackson lmmunoResearch (West Grove, PA); monoclo- 
nal anti-phosphotyrosine a tibody (PY-20), polyclonal anti-Pl 3-ki- 
nase p85 antibody and rabbit anti-Cbl antibody from Santa Cruz 
(California)', nSl-protein G from New England Nuclear; phospholi- 
pids from Avanti Polar Lipids Inc. All other eagents from commer- 
cial sources were of analytical grade. 
2.2. Cells 
The human monocytic cell line THP-! obtained from the American 
Type Culture Collection was maintained in the RPMI 1640 medium 
supplemented with 10% fetal calf serum, penicillin (100 U/ml). strep- 
tomycin (100 I~g/ml) and 20 mM HI~P~S (pit 7.2). The cells had been 
cultured with 0.5 mM dibutyryl cAMP for 72 h before use. 
2.3. Cross-linking of FcyRs on THP-I cells 
The cultured cells were washed twice and suspended in Krebs-Ring- 
er-HEPES buffer 034 mM NaCi, 4.7 mM KCi, 1.2 mM KH2PO4, 1.2 
mM MgSO4, 2.5 mM CaCI2, 5 mM glucose, 0.2% bovine serum 
albumin, 20 mM HEPES, pH 7.4). Aliquots (10 T ceils/0.5 ml) of the 
cell suspension were first treated with monoclonal IV. 3 (anti-FcyRll) 
(1 pg/ml) for 2¢ min on ice and warmed to 37°C for 5 min and cross- 
linked with l'J ~tg/ml of goat anti-mouse IgG for the period indicaled. 
The reacticas were terminated with 0.5 ml of ice-cold lysis buffer 
consistinlg of 2% NP-40, 4 mM NaVOj, 100 mM NaF, 40 mM 
HEPES (pH 7.8), 100 units/ml of aprotinin, 2 mM PMSF, 2 mM 
dithiothreitol, 10 mM EDTA and 0.2% bovine serum albumin. 
S0014.5793/96/$12.00 © 1996 Federation of European Biochemical Societies. All rights reserved, 
SSDIS0014-5793(96)001 22-6 
12 T. Matsuo et al.IFEBS Letters 382 (1996) 11-14 
(K) 
• ..-.- 200 
116 
• - - -  97.5 
m 66 
. . . . . .  i ........... ~ " ~ 45 
0 0,170.250.5 1 2 4 8 12 16 Time(min) 
Fig. I. Time course of protein tyrosine phosphorylation after cross- 
linking for FelrR. THP-! cells treated with monoclonal antibody 
against FeyRII at 0°C for 25 rain were incubated at 370C for 5 min 
without any further addition and then with the F(ab'h fragment of 
goat anti.mouse lgG for the period indicated at the bottom of pa- 
nel, After incubation, the cells were lysed with NP-40, and phospho- 
tyrosine-containing proteins were immunoprecipitated with anti° 
phosphotyrosine antibodies (PY.20). lmmunoprecipitates were then 
analyzed by SDS-PAGE followed by immunobiotting with polyclo- 
nal rabbit anti.phosphotyrosine antibodies. Mobility of the protein 
standards is indicated in kDa of molecular masses. The data are 
from a typical experiment representative of more than three. 
2,4, lmmuaoprecipitation and immunoblotting 
The ~II lysate was precleared with preimmune lgG and protein G. 
Sepharose at 4°C for ! h, and subjected to immunoprecipitation with 
appropriate antibodies for more than I h, and then with the addition 
of protein G-Sepharose for I h or a longer period of time. After 
repeated washings, immunoprecipitates were heated at 100"C for 
3 rain in 30 pl of the sample buffer consisting of 1% SDS, 10% 
glycerol, 5% 2-mercaptoethanol, 0.02% bromophenol blue and 62.5 
mM Tris (pH 6.8). Solubilized peptides were then separated by SDS- 
PAGE on 7.5% slab gel and transferred electrophoretically to a ni- 
trocellulose membrane at 2 mA/cm afor 40 rain, After blocking in 3% 
fatty acid-free bovine serura albumin, the blot was incubated with 
appropriate antibodies, washed, and then with n~I-protein G, Follow- 
ing repeated washings, associated radioactivity was visualized with a 
Fuji gAS2000 bioimaging analyzer. 
2,5, Assay of P! 3.kinase activities 
The anti-phosphotyrosine (PY-20), anti-Cbl or anti-p85 immuno. 
precipitates were assayed for their Pl 3.kinase activities. The immu- 
noprecipitates prepared as above were washed twice with the buffer 
~;ondsting of 40 mM Tris-HCI (pH 7,4), 5 mM EDTA and 1% NP-40, 
twice with the same buffer supplemented with 0,5 M LiCI, and three 
times with the buffer supplemented with 100 mM CaCI, Aliquots 
(2x l0 ~ celh eq,) of immunoprecipitates were suspended in 0,I ml 
of the reactiot= mixture consisting of 40 mM THs-HCI (pH 7.4), 0.5 
mM EGTA, 0,2 w,M PI, 0,2 mM phosphatidylserine, 5 mM MgCIa, 
and 0,I mM (2 p.Ci) [~,-=P]ATP, The reaction was allowed to proceed 
at YPC for I$ rain befot.e termination by the addition of 20 Id of 8% 
HCIO4 and 0,45 ml of chloroform/methanol (1:2), After vigorous 
stirring, the mixture was added with 0.15 ml of chloroform and 
0,15 ml of 8% HCIO4 to separate the organic phase, which was 
washed with chloroform-saturated 0,5M NaCI containing I% HCIO4 
and then evaporated todryness. The extract was dissolved in 30 Id of 
chloroform/methanol (9:1) to be spotted on a silica gel plate (Silica 
Gel 60, Merck), The plate was developed inchloroform/methanol/28% 
NH4OH/H=O (70:100:25:15), dried, and visualized for radioactivities 
in the PI-3P fraction with a Fuji BAS2000 bioimaging analyzer. 
3, Remits and diseu~on 
3, I, Protein tyrosiae phosphorylation after F¢~IRH cross-linking 
Cross-linking of Fc~l l  on THP-I cells with monoclonal 
anti-F¢~II  antibody and F(ab'h fragment of anti-mouse IgG 
induced tyrosine phosphorylation of several proteins with too- 
lecular masses of approximately 200, 160, 140, 100-130, 95, 
75, 70, 62, 53, 47 and 44 kDa (Fig. 1). The phosphorylation of
most of these proteins was observed within 15 s after stimula- 
tion and peaked at 1 min and then gradually decreased up to 
16 min. Several ines of evidence have raised the possibility 
that tyrosine phosphorylation of Cbl might be involved in 
immune recognition systems in hematopoietic cells [11-17]. 
To test the tyrosine phosphorylation of Cbl upon FcvR sti- 
mulation, whole cell lysates were immunoprecipitated with 
anti-phosphotyrosine antibodies (PY20) and analyzed by blot- 
ting with anti-Cbl antibodies. As shown in Fig. 2, phosphor- 
ylation of Cbl migrating with a mobility corresponding to 120 
kDa was observed within 15 s after stimulation and reached a
maximum at 1 rain and then decreased to almost the basal 
level at 8 rain. 
3.2. Association of Pl 3-kinase activiO, with anti-Cbl antibo@ 
upon FolRH cross-linking 
In a previous study, we have sought the tyrosine phos- 
phorylated proteins that are associated with the 85-kDa sub- 
unit of PI 3-kinase during Fq, R-dependent activation of Pl 3- 
kinase [34]. Cross-linking of FcyR resulted in association of 
several tyrosine-phosphorylated proteins with the lipid kinase. 
Among them, the 115-kDa protein bound to p85 so firmly as 
to be observable ven after heat and acid denaturation of 
proteins [34]. Cbl is a possible candidate for the 115-kDa 
c-Cbl 'p "' 
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Fig. 2. Time course of tyrosine phosphorylation of Cbl after cross- 
linking of F¢~RII. THP-i cells treated with monoclonal antibodies 
against Fc'/RII were incubated with the F(ab'h fragment of goat 
anti-mouse lgG for the indicated times. The cells were lyzed, and 
anti-phosphotyrosine immunoprecipitates were analyzed by immuno- 
blotting with anti-Cbl antibodies (upper panel). The phosphoryla. 
tion was quantified by an image analyzer and plotted in an arbi- 
trary unit as a function of incubation time (lower panel). T',e data 
are from a typical experiment; similar results were obtair~ed three 
times. 
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Fig. 3. Increased PI 3-kinase activity in anti-phosphotyrosine a d
anti-Cbl immunoprecipitates after crosslinking of FcTRII. THP-I 
cells untreated (O) or treated (O) with monoclonal ntibody against 
F~RII were incubated with F(ab')s fragment of a goat anti-mouse 
IgG for the indicated times before the extraction with NP-40. PI 3- 
kinase activities immunoprecipitated with anti-phosphotyrosine (a) 
or anti-Cbl (b) were measured as described under section 2. 
The generation of PI-3P was quantified by an image analyzer 
and plotted in an arbitrary unit as a functior, f incubation time. 
(c) THP-I cells untreated (open column', Cross-Linking -) or trea- 
ted (dotted column; C-L +) with monoclonal ntibodies against 
FcyRII were incubated with F(ab')2 fragment of goat anti-mouse 
IgG for I rain. Pl 3-kinase activities immunoprecipitated (IP)with 
anti-Cbl or PY-20 were measured as above. 
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Fig. 4. Association of tyrosine..phosphorylated Cbl with the 85-kDa 
subunit (p85) of PI 3-kinasc after crosslinking of FcTRII. THP-! 
cells untreated (lanes 1, 3, 5, 6 and 8 as shown by [-]) or treated 
(lanes 2, 4 and 7 [+]) with monoclonal ntibody against Fc'tRII 
were incubated with the F(ab')2 fragment of goat anti-mouse IgG 
for 1 rain before the extraction with 1% NP.40.containing buffer. 
Proteins in the extract were immunoprecipitated (IP)with anti-Cbl 
antibodies (lanes !, 2, 5, 6 and 7 as shown by [anti-Cbi]) or with 
anti-p85 antibodies (lanes 3, 4 and 8 [anti-p85]), separated by SDS- 
PAGE and analyzed by immunoblotting (IB) with PY-20 (lanes !
and 2), anti-Cbl antibodies (lanes 3--5) or anti-p85 antibodies (lanes 
6-8). The data are from a typical experiment after similar esults 
have been obtained more than three times. 
protein. Crosslinking the F~RII on THP-I cells caused a 
marked increase in the PI 3-kinase activity in the anti-phos- 
photyrosine (Fig. 3a) and anti-Cbl (Fig. 3b) immunoprecipi- 
tates from the whole cell lysate. The maximum activation was 
observed at I min in both fractions (Fig. 3a,b). Although the 
amount of PI 3-kinase in Cbl immunoprecipitates r presented 
only a small fraction (4-5%) of the total p85 pool, most frac- 
tion (roughly 85 percent) of the increments in PI 3-kinase 
activity of anti-phosphotyrosine immunoprecipitates upon 
Fc~R engagement was accounted for by the enzyme activity 
increment in anti-Cbl immunoprecipitates in the same experi- 
ments (Fig. 3c). 
3.3. Specific association of Cbi with PI 3-kinase 
Crosslinking of F~RII resulted in tyrosine phosphorylation 
of Cbl as observed in experiments in which immunoprecipita- 
tion of cell lysates with anti-Cbi was followed by immunobiot- 
ting with PY20 (Fig. 4, lanes 1 and 2) or inversely immune- 
precipitation with PY20 was followed by immunoblotting 
with anti-Cbl, as shown in time-course data in Fig. 2. The 
thus phosphorylated Cbl, which migrated at a slightly lower 
rate than did the non-phosphorylation one upon SDS-PAGE, 
was mostly associated with the regulatory subunit of PI 3- 
kinase as detected by immunoprecipitation with anti-p85 anti- 
body followed by immunoblotting with anti-Cbl antibody 
(Fig. 4, lanes 3-5). The association was again observed 
when two antibodies used were replaced each other for im- 
munoprecipitation a d immunoblotting (Fig. 4, lanes 6-8). 
The tight association of tyrosine-phosphorylated Cbl with 
p85, upon Fc),R stimulation, is very likely to be responsible 
for marked increases in PI 3-kinase activity in anti-Cbl and 
anti-phosphotyrosine mmunoprecipitates observed under si- 
milar conditions in Fig. 3. The increase in PI 3-kinase must 
be essential for FcTR-mediated phagocytosis, ince it was to- 
tally blocked by wortmannin, a selective inhibitor of the en- 
zyme [34]. The initial step of signaling following ligand en- 
gagement of Fc'/RII could be activation of a non-receptor- 
type protein-tyrosine kinase, one of the substrates of which 
is Cbl, as actually reported for Lyn in HL-60 cells [5] and 
FynlLck in human jurkat T-cells [I 5]. Cbl proteins thus phos- 
phorylated on tyrosines hould associate with SH2 domains of 
p85 because the direct association between Cbl and p85 is 
reported in vitro using a fusion protein comprising the SH2 
domains of p85 in CD3-activated jurkat T cells [13]. Actually, 
in THP-I cells, the binding between Cbl and p85 was almost 
completely blocked by phenyl phosphate which competitively 
inhibits the binding between tyrosine phosphorylated protein 
and the SH2 domain (paper in preparation). Furthermore, 
when anti-Cbl antibody immunoprecipitate was separated by 
SDS-PAGE, blotted to a membrane, and probed with GST- 
p85 fusion protein and anti-GST antibody, the bound GST- 
p85 was detectable at the position of Cbl migrated (paper in 
preparation). The direct binding of phosphorylated Cbl to PI 
3-kinase must lead to phagocytosis a  a result of activation of 
the lipid kinase. A possibility could not be excluded, however, 
for other signaling roles of Cbl, which is capable of binding to 
SH3 domains of intracellular proteins via its proline-rich mo- 
tifs [36,37]. In fact, Grb2/Ash coprecipitated with Cbl from 
lysates of stimulated or unstimulated THP-1 cells (unpub- 
lished observation), in accordance with previous reports on 
T-cell lines [12,15]. Such adaptor proteins might mediate 
Ras-MAP kinase cascades via Sos, an activator of small 
GTP-binding proteins. These possibilities would be the sub- 
jects of further investigations. 
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